The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
Open accessAbstract
The kinase activities of the cyclin/cdk complexes can be regulated in a number of ways. The most recently discovered mechanism of regulation is the association of cdk inhibitors (CKIs), such as p21, p27, and p57, with these complexes. In this report we demonstrate that the pRB-related protein p107, like the p21 family of cdk inhibitors, can inhibit the phosphorylation of target substrates by cyclin A/cdk2 and cyclin E/cdk2 complexes, and the associations of p107 and p21 with cyclin/cdk2 rely on a structurally and functionally related interaction domain. Furthermore, interactions between p107 or p21 with cyclin/cdk2 complexes are mutually exclusive. In cells treated with DNA-damaging agents elevated levels of p21 cause a dissociation of p107/cyclin/cdk2 complexes to yield p21/cyclin/cdk2 complexes. Finally, the consequences of cyclin/cdk2 interactions with p107 have been examined. The activation of the p107-bound cyclin/cdk kinases leads to dissociation of p107 from the transcription factor E2F. Together, these results suggest that cyclin/cdk complexes can be regulated by protein molecules from different families in a mutually exclusive manner in response to certain signals and that these inhibitory proteins may have a potential role in regulating macromolecular assembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Self-citationD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson, M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 794
Self-citationGuan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
Hirai, H., Roussel, M. F., Kato, J.-Y., Ashmun, R. A., & Sherr, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2672 · Cited by 646
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548
TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
Ewen, M. E., Sluss, H. K., Whitehouse, L. L., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90723-4 · Cited by 528
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 514
Self-citationIsolation of the Rb-related p130 through its interaction with CDK2 and cyclins.
Hannon, G. J., Demetrick, D., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2378 · Cited by 465
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase
Tsai, L.-H., Harlow, E., & Meyerson, M. (1991) · Nature · doi:10.1038/353174a0 · Cited by 461
Self-citationJoining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
Peter, M. (1994) · Cell · doi:10.1016/0092-8674(94)90186-4 · Cited by 445
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees, E., Faha, B., Dulic, V, Reed, S. I., & Harlow, E. (1992) · Genes & Development · doi:10.1101/gad.6.10.1874 · Cited by 438
Self-citationIdentification of a growth suppression domain within the retinoblastoma gene product.
Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404
Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
Dynlacht, B. D., Flores, O., Lees, J. A., & Harlow, E. (1994) · Genes & Development · doi:10.1101/gad.8.15.1772 · Cited by 395
Self-citationIdentification of Human and Mouse p19, a Novel CDK4 and CDK6 Inhibitor with Homology to p16ink4
Chan, F. K. M., Zhang, J., Cheng, L., Shapiro, D. N., & Winoto, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2682 · Cited by 339
Li, Y., Graham, C., Lacy, S., Duncan, A. M., & Whyte, P. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2366 · Cited by 337
E2F-4, a new member of the E2F transcription factor family, interacts with p107.
Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z. X., Xu, G., Wydner, K. L., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.22.2665 · Cited by 330
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.
Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlée, L., Voorhoeve, P. M., & Bernards, R. (1994) · Genes & Development · doi:10.1101/gad.8.22.2680 · Cited by 322
Self-citationGeng, Y., & Weinberg, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10315 · Cited by 277
An Inhibitor of p34 CDC28 Protein Kinase Activity from Saccharomyces cerevisiae
Mendenhall, M. D. (1993) · Science · doi:10.1126/science.8421781 · Cited by 228
Interaction of p107 with Cyclin A Independent of Complex Formation with Viral Oncoproteins
Ewen, M. E., Faha, B., Harlow, E., & Livingston, D. M. (1992) · Science · doi:10.1126/science.1532457 · Cited by 226
Self-citationInteraction Between Human Cyclin A and Adenovirus E1A-Associated p107 Protein
Faha, B., Ewen, M. E., Tsai, L.-H., Livingston, D. M., & Harlow, E. (1992) · Science · doi:10.1126/science.1532458 · Cited by 210
Self-citationIvey-Hoyle, M., Conroy, R., Huber, H. E., Goodhart, P. J., Oliff, A., & Heimbrook, D. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7802 · Cited by 194
A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes.
Peeper, D. S., Parker, L. L., Ewen, M. E., Toebes, M., Hall, F. L., Xu, M., Zantema, A., van der Eb, A. J., & Piwnica-Worms, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05844.x · Cited by 191
Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.
Nakanishi, M., Robetorye, R. S., Adami, G. R., Pereira-Smith, O. M., & Smith, J. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07031.x · Cited by 178
The retinoblastoma protein as a transcriptional repressor
Helin, K., & Ed, H. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90150-y · Cited by 167
Zhu, L., Enders, G. H., Lees, J. A., Beijersbergen, R. L., Bernards, R., & Harlow, E. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07182.x · Cited by 134
Self-citationAntibodies Specific for the Human Retinoblastoma Protein Identify a Family of Related Polypeptides
Hu, Q., Bautista, C., Edwards, G. M., Defeo-Jones, D., Jones, R. E., & Harlow, E. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5792 · Cited by 125
Self-citationThe Rb-Related p107 Protein Can Suppress E2F Function Independently of Binding to Cyclin A/cdk2
Smith, E., & Nevins, J. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.338 · Cited by 52
Cited by
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Self-citationThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,102
Metadata
- Authors
- Zhu, L., Harlow, E., & Dynlacht, B. D.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1995-07-15
- Volume
- 9
- Issue
- 14
- Pages
- 1740-1752
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W1996237823
- Cited by
- 252
- References
- 48
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.